
Arvinas
IPOTargeted Protein Degradation Therapeutics
Arvinas is a biotech company in New Haven, United States, founded in 2013. It has raised $465.9M across 5 rounds, most recently a $350.0M Private Equity in November 2023.
- Headquarters
- New Haven, Connecticut
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- arvinas.com
- Total Funding
- $465.9M
- Last Round
- $350.0M Private EquityNov 2023
- Rounds
- 5
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 14 investors for this company. to use credits for reveals, or explore the API.
About
Arvinas is a clinical-stage biopharmaceutical company and pioneer of PROTAC protein degrader technology, harnessing the body's own ubiquitin-proteasome system to selectively degrade disease-causing proteins. Its pipeline spans oncology and neurology, with lead programs targeting the androgen receptor (ARV-110) and estrogen receptor (ARV-471) in partnership with Pfizer. The company's platform addresses historically undruggable targets, offering potential advantages over traditional inhibitor approaches.
Funding & Exit History
Nov 2023
5 more events
- IPO20181 investor
- Series C20189 investors
- Grant2016
Funding: Series A through Private Equity. Amounts, valuations, and investors where available.
Investors
Canaan Partners
3 rounds
5AM Ventures
3 rounds
RA Capital Management
2 rounds
EcoR1 Capital
1 round

RTW Investments
1 round
Nextech Invest
1 round
OrbiMed
2 rounds
New Leaf Venture Partners
2 rounds
Nasdaq Ventures
1 round

Deerfield Management
1 round

Hillhouse Capital
1 round

Sirona Capital
1 round
Connecticut Innovations
1 round
Elm Street Ventures
1 round
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- Backend ×2
- Frontend ×2
- DevOps ×1
- Marketing & SEO ×1
- Other ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Calico researches human aging using advanced technologies and model systems, applying that knowle...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arvinas"><img src="https://indexed.vc/api/badge/company/arvinas" alt="Arvinas on Indexed.vc" width="260" height="76" /></a>